Mount Sinai
We have committed $20 million to Mount Sinai to promote health equity in the United States and across the world.
The Mount Sinai-Royalty Pharma Alliance for Health Equity Research leverages our proprietary data and Mount Sinai’s population data to identify racial and other inequities in how patients with common diseases are treated—and the outcomes of treatment.
This research is helping to translate medical discoveries into sustainable, scalable initiatives and policies that break down systemic barriers to care.